Supreme Court Blocks Restrictions on Abortion Pill Mifepristone, Ensuring Continued Access

The U.S. Supreme Court on Thursday issued an order preserving access to mifepristone, the drug most commonly used in medication abortions. The decision temporarily blocks restrictions imposed by lower courts while a broader legal battle continues.

The court’s order allows women to obtain mifepristone at pharmacies or through the mail without needing an in-person visit to a doctor. This access is expected to remain in place at least until next year as the case proceeds, including any potential appeal to the Supreme Court.

Background of the Legal Battle

The dispute began after the U.S. Food and Drug Administration (FDA) approved mifepristone in 2000. The drug, used in combination with misoprostol, has been widely prescribed for decades to terminate pregnancies up to 10 weeks.

In 2022, the FDA reaffirmed the safety and efficacy of mifepristone, maintaining its availability through telehealth and mail-order pharmacies. However, a coalition of anti-abortion groups and doctors filed a lawsuit in November 2022 challenging the FDA’s approval and subsequent regulations.

Key Details of the Supreme Court’s Order

The Supreme Court’s order did not rule on the merits of the case but instead focused on the immediate availability of mifepristone. The decision was made without full briefing or oral arguments, signaling the court’s intent to maintain the status quo while legal proceedings advance.

Justice Samuel Alito, joined by Justice Clarence Thomas, dissented from the order. They argued that the court should have allowed restrictions imposed by the Fifth Circuit Court of Appeals to take effect. The majority, however, did not provide an explanation for their decision.

Impact on Abortion Access

The Supreme Court’s order ensures that mifepristone remains accessible to patients in states where abortion is legal. The drug can be prescribed via telehealth consultations and delivered by mail, reducing barriers for many women.

Abortion rights advocates praised the decision, while opponents vowed to continue their legal challenges. The case is expected to reach the Supreme Court for a final ruling in the coming months.